Law Office of Brodsky & Smith, LLC Announces Class Action Lawsuit Against Monogram Biosciences, Inc.

BALA CYNWYD, PA, Jun 30 (MARKET WIRE) --
Law office of Brodsky & Smith, LLC announces that a class action lawsuit
has been filed in the Superior Court of California challenging the
proposed acquisition of Monogram Biosciences, Inc. ("Monogram
Biosciences" or the "Company") (NASDAQ: MGRM) by Laboratory Corporation
of America Holdings ("LabCorp") (NYSE: LH). LabCorp has agreed to acquire
Monogram Biosciences in an all-cash deal valued at approximately $106.7
million ($155 million, including indebtedness).

Under the proposed agreement, Monogram Biosciences shareholders will
receive $4.55 for every share of Monogram Biosciences common stock they
own. The investigation concerns possible breaches of fiduciary duty and
other violations of state law related to the Monogram Biosciences Board's
approval of the proposed merger. The transaction appears to be unfair, in
part, given that Monogram Biosciences stock was trading at over $4.35 a
share as recently as February 2009 and traded at over $5.00 a share into
the 4th quarter of 2008.

If you own shares of Monogram Biosciences and wish to discuss the legal
ramifications of the proposed acquisition by LabCorp, or have any
questions, you may e-mail or call the law office of Brodsky & Smith, LLC
who will, without obligation or cost to you, attempt to answer your
questions. You may contact Jason L. Brodsky, Esquire or Marc Ackerman,
Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd,
PA 19004, by e-mail at clients@brodsky-smith.com, or by calling toll free
877-LEGAL-90.

Contact:
Jason L. Brodsky, Esquire
Marc Ackerman, Esquire
Brodsky & Smith, LLC
Two Bala Plaza, Suite 602
Bala Cynwyd, PA 19004
Email Contact
877-LEGAL-90

Copyright 2009, Market Wire, All rights reserved.

-0-